Rekah Pharmaceutical Industry Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REKA.TA research report →
Price Chart
About the company
Rekah Pharmaceutical Industry Ltd. , established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements.
- CEO
- Mordechai Elgrabli
- IPO
- 2002
- Employees
- 390
- HQ
- Holon, TA, IL
Get TickerSpark's AI analysis on REKA.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $120.54M
- P/E
- -6.48
- PEG
- 0.02
- P/S
- 0.40
- P/B
- 0.85
- EV/EBITDA
- 11.02
- Div Yield
- 0.00%
- Gross Margin
- 22.12%
- Op Margin
- -2.43%
- Net Margin
- -6.10%
- ROE
- -12.54%
- ROIC
- -2.48%
Latest fiscal year · YoY change
- Revenue
- $300.99M-6.4%
- Gross Profit
- $58.17M-19.2%
- Op Income
- $-6,263,000
- Net Income
- $-18,074,000-391.2%
- EPS
- $-1.58-403.8%
- OCF Growth
- -51.2%
- FCF Growth
- -66.8%
- 52W High
- $1348.00
- 52W Low
- $1006.00
- 50D MA
- $1067.28
- 200D MA
- $1139.55
- Beta
- 0.11
- RSI (14)
- 46
- Avg Volume
- 3.67K
No earnings-call transcripts are available for REKA.TA yet.
- Free Float
- 16.5%
- Shares Outstanding
- 11.41M
- Float Shares
- 1.88M
Our REKA.TA coverage
Recent articles, reports, and earnings notes.
No research on REKA.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate REKA.TA report →